Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Synthesis and Penicillin-binding Protein Inhibitory Assessment of Dipeptidic 4-Phenyl-β-lactams from α-Amino Acid-derived Imines.

Decuyper L, Jukič M, Sosič I, Amoroso AM, Verlaine O, Joris B, Gobec S, D'hooghe M.

Chem Asian J. 2019 Nov 5. doi: 10.1002/asia.201901470. [Epub ahead of print]

PMID:
31686429
2.

α-Unsaturated 3-Amino-1-carboxymethyl-β-lactams as Bacterial PBP Inhibitors: Synthesis and Biochemical Assessment.

Decuyper L, Magdalenić K, Verstraete M, Jukič M, Sosič I, Sauvage E, Amoroso AM, Verlaine O, Joris B, Gobec S, D'hooghe M.

Chemistry. 2019 Oct 9. doi: 10.1002/chem.201904139. [Epub ahead of print]

PMID:
31596974
3.

Single-molecule force spectroscopy to decipher the early signalling step in membrane-bound penicillin receptors embedded into a lipid bilayer.

Mescola A, Dauvin M, Amoroso A, Duwez AS, Joris B.

Nanoscale. 2019 Jul 7;11(25):12275-12284. doi: 10.1039/c9nr02466b. Epub 2019 Jun 18.

PMID:
31211302
4.

Bacillus licheniformis peptidoglycan characterization by CZE-MS: Assessment with the benchmark RP-HPLC-MS method.

Boulanger M, Delvaux C, Quinton L, Joris B, De Pauw E, Far J.

Electrophoresis. 2019 Oct;40(20):2672-2682. doi: 10.1002/elps.201900147. Epub 2019 Jun 13.

PMID:
31169927
5.

Unaccounted risk of cardiovascular disease: the role of the microbiome in lipid metabolism.

Joris BR, Gloor GB.

Curr Opin Lipidol. 2019 Apr;30(2):125-133. doi: 10.1097/MOL.0000000000000582.

PMID:
30664014
6.

1-(2-Hydroxybenzoyl)-thiosemicarbazides are promising antimicrobial agents targeting d-alanine-d-alanine ligase in bacterio.

Ameryckx A, Thabault L, Pochet L, Leimanis S, Poupaert JH, Wouters J, Joris B, Van Bambeke F, Frédérick R.

Eur J Med Chem. 2018 Nov 5;159:324-338. doi: 10.1016/j.ejmech.2018.09.067. Epub 2018 Sep 28.

PMID:
30300845
7.

In Silico Design and Enantioselective Synthesis of Functionalized Monocyclic 3-Amino-1-carboxymethyl-β-lactams as Inhibitors of Penicillin-Binding Proteins of Resistant Bacteria.

Decuyper L, Deketelaere S, Vanparys L, Jukič M, Sosič I, Sauvage E, Amoroso AM, Verlaine O, Joris B, Gobec S, D'hooghe M.

Chemistry. 2018 Oct 12;24(57):15254-15266. doi: 10.1002/chem.201801868. Epub 2018 Sep 13.

PMID:
29882610
8.

Draft Genome Sequence of the Axenic Strain Phormidesmispriestleyi ULC007, a Cyanobacterium Isolated from Lake Bruehwiler (Larsemann Hills, Antarctica).

Lara Y, Durieu B, Cornet L, Verlaine O, Rippka R, Pessi IS, Misztak A, Joris B, Javaux EJ, Baurain D, Wilmotte A.

Genome Announc. 2017 Feb 16;5(7). pii: e01546-16. doi: 10.1128/genomeA.01546-16.

9.

Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain.

Di Gregorio S, Fernandez S, Cuirolo A, Verlaine O, Amoroso A, Mengin-Lecreulx D, Famiglietti A, Joris B, Mollerach M.

Microb Drug Resist. 2017 Jan;23(1):44-50. doi: 10.1089/mdr.2016.0160. Epub 2016 Dec 19.

10.

Enterococcus hirae LcpA (Psr), a new peptidoglycan-binding protein localized at the division site.

Maréchal M, Amoroso A, Morlot C, Vernet T, Coyette J, Joris B.

BMC Microbiol. 2016 Oct 12;16(1):239.

11.

A Lysine Cluster in Domain II of Bacillus subtilis PBP4a Plays a Role in the Membrane Attachment of This C1-PBP.

Vanden Broeck A, Van der Heiden E, Sauvage E, Dauvin M, Joris B, Duez C.

PLoS One. 2015 Oct 13;10(10):e0140082. doi: 10.1371/journal.pone.0140082. eCollection 2015.

12.

Synthesis and Physicochemical Characterization of D-Tagatose-1-Phosphate: The Substrate of the Tagatose-1-Phosphate Kinase in the Phosphotransferase System-Mediated D-Tagatose Catabolic Pathway of Bacillus licheniformis.

Van der Heiden E, Delmarcelle M, Simon P, Counson M, Galleni M, Freedberg DI, Thompson J, Joris B, Battistel MD.

J Mol Microbiol Biotechnol. 2015;25(2-3):106-19. doi: 10.1159/000370115. Epub 2015 Jul 9.

13.

5'-Methylene-triazole-substituted-aminoribosyl uridines as MraY inhibitors: synthesis, biological evaluation and molecular modeling.

Fer MJ, Bouhss A, Patrão M, Le Corre L, Pietrancosta N, Amoroso A, Joris B, Mengin-Lecreulx D, Calvet-Vitale S, Gravier-Pelletier C.

Org Biomol Chem. 2015 Jul 14;13(26):7193-222. doi: 10.1039/c5ob00707k. Epub 2015 May 26.

14.

Genome-wide transcriptional analysis suggests hydrogenase- and nitrogenase-mediated hydrogen production in Clostridium butyricum CWBI 1009.

Calusinska M, Hamilton C, Monsieurs P, Mathy G, Leys N, Franck F, Joris B, Thonart P, Hiligsmann S, Wilmotte A.

Biotechnol Biofuels. 2015 Feb 22;8:27. doi: 10.1186/s13068-015-0203-5. eCollection 2015.

15.

Enantioselective synthesis of α-benzylated lanthionines and related tripeptides for biological incorporation into E. coli peptidoglycan.

Denoël T, Zervosen A, Lemaire C, Joris B, Hervé M, Blanot D, Zaragoza G, Luxen A.

Org Biomol Chem. 2014 Dec 28;12(48):9853-63. doi: 10.1039/c4ob01476f.

PMID:
25355616
16.

Stereoselective synthesis of lanthionine derivatives in aqueous solution and their incorporation into the peptidoglycan of Escherichia coli.

Denoël T, Zervosen A, Gerards T, Lemaire C, Joris B, Blanot D, Luxen A.

Bioorg Med Chem. 2014 Sep 1;22(17):4621-8. doi: 10.1016/j.bmc.2014.07.023. Epub 2014 Jul 23.

PMID:
25124861
17.

Characterization of amylolysin, a novel lantibiotic from Bacillus amyloliquefaciens GA1.

Arguelles Arias A, Ongena M, Devreese B, Terrak M, Joris B, Fickers P.

PLoS One. 2013 Dec 9;8(12):e83037. doi: 10.1371/journal.pone.0083037. eCollection 2013.

18.

Dual mode of action of amylolysin: a type-B lantibiotic produced by Bacillus amyloliquefaciens GA1.

Arguelles Arias A, Joris B, Fickers P.

Protein Pept Lett. 2014 Apr;21(4):336-40.

PMID:
24164268
19.

Activity of ceftaroline against Enterococcus faecium PBP5.

Henry X, Verlaine O, Amoroso A, Coyette J, Frère JM, Joris B.

Antimicrob Agents Chemother. 2013 Dec;57(12):6358-60. doi: 10.1128/AAC.00923-13. Epub 2013 Sep 23.

20.

Synthesis and biological evaluation of potential threonine synthase inhibitors: Rhizocticin A and Plumbemycin A.

Gahungu M, Arguelles-Arias A, Fickers P, Zervosen A, Joris B, Damblon C, Luxen A.

Bioorg Med Chem. 2013 Sep 1;21(17):4958-67. doi: 10.1016/j.bmc.2013.06.064. Epub 2013 Jul 8.

PMID:
23891162
21.

SAHBNET, an accessible surface-based elastic network: an application to membrane protein.

Dony N, Crowet JM, Joris B, Brasseur R, Lins L.

Int J Mol Sci. 2013 May 30;14(6):11510-26. doi: 10.3390/ijms140611510.

22.

A pathway closely related to the (D)-tagatose pathway of gram-negative enterobacteria identified in the gram-positive bacterium Bacillus licheniformis.

Van der Heiden E, Delmarcelle M, Lebrun S, Freichels R, Brans A, Vastenavond CM, Galleni M, Joris B.

Appl Environ Microbiol. 2013 Jun;79(11):3511-5. doi: 10.1128/AEM.03918-12. Epub 2013 Mar 22.

23.

Exploration of the chemical space of novel naphthalene-sulfonamide and anthranilic Acid-based inhibitors of penicillin-binding proteins.

Sosič I, Turk S, Sinreih M, Trošt N, Verlaine O, Amoroso A, Zervosen A, Luxen A, Joris B, Gobec S.

Acta Chim Slov. 2012 Jun;59(2):280-388.

PMID:
24061241
24.

Bacillus licheniformis BlaR1 L3 loop is a zinc metalloprotease activated by self-proteolysis.

Berzigotti S, Benlafya K, Sépulchre J, Amoroso A, Joris B.

PLoS One. 2012;7(5):e36400. doi: 10.1371/journal.pone.0036400. Epub 2012 May 18.

25.

Fermentative hydrogen production from glucose and starch using pure strains and artificial co-cultures ofClostridium spp.

Masset J, Calusinska M, Hamilton C, Hiligsmann S, Joris B, Wilmotte A, Thonart P.

Biotechnol Biofuels. 2012 May 22;5(1):35. doi: 10.1186/1754-6834-5-35.

26.

Synthesis and evaluation of boronic acids as inhibitors of Penicillin Binding Proteins of classes A, B and C.

Zervosen A, Bouillez A, Herman A, Amoroso A, Joris B, Sauvage E, Charlier P, Luxen A.

Bioorg Med Chem. 2012 Jun 15;20(12):3915-24. doi: 10.1016/j.bmc.2012.04.018. Epub 2012 Apr 16.

27.

Synthesis of modified peptidoglycan precursor analogues for the inhibition of glycosyltransferase.

Dumbre S, Derouaux A, Lescrinier E, Piette A, Joris B, Terrak M, Herdewijn P.

J Am Chem Soc. 2012 Jun 6;134(22):9343-51. doi: 10.1021/ja302099u. Epub 2012 May 25.

28.

A peptidoglycan fragment triggers β-lactam resistance in Bacillus licheniformis.

Amoroso A, Boudet J, Berzigotti S, Duval V, Teller N, Mengin-Lecreulx D, Luxen A, Simorre JP, Joris B.

PLoS Pathog. 2012;8(3):e1002571. doi: 10.1371/journal.ppat.1002571. Epub 2012 Mar 15.

29.

Genetic diversity and amplification of different clostridial [FeFe] hydrogenases by group-specific degenerate primers.

Calusinska M, Joris B, Wilmotte A.

Lett Appl Microbiol. 2011 Oct;53(4):473-80. doi: 10.1111/j.1472-765X.2011.03135.x. Epub 2011 Sep 6.

30.

Structure-guided design of cell wall biosynthesis inhibitors that overcome β-lactam resistance in Staphylococcus aureus (MRSA).

Contreras-Martel C, Amoroso A, Woon EC, Zervosen A, Inglis S, Martins A, Verlaine O, Rydzik AM, Job V, Luxen A, Joris B, Schofield CJ, Dessen A.

ACS Chem Biol. 2011 Sep 16;6(9):943-51. doi: 10.1021/cb2001846. Epub 2011 Aug 3.

PMID:
21732689
31.

Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein.

Zervosen A, Herman R, Kerff F, Herman A, Bouillez A, Prati F, Pratt RF, Frère JM, Joris B, Luxen A, Charlier P, Sauvage E.

J Am Chem Soc. 2011 Jul 20;133(28):10839-48. doi: 10.1021/ja200696y. Epub 2011 Jun 24.

32.

New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria.

Turk S, Verlaine O, Gerards T, Zivec M, Humljan J, Sosič I, Amoroso A, Zervosen A, Luxen A, Joris B, Gobec S.

PLoS One. 2011 May 9;6(5):e19418. doi: 10.1371/journal.pone.0019418.

33.

Second-generation sulfonamide inhibitors of D-glutamic acid-adding enzyme: activity optimisation with conformationally rigid analogues of D-glutamic acid.

Sosič I, Barreteau H, Simčič M, Sink R, Cesar J, Zega A, Grdadolnik SG, Contreras-Martel C, Dessen A, Amoroso A, Joris B, Blanot D, Gobec S.

Eur J Med Chem. 2011 Jul;46(7):2880-94. doi: 10.1016/j.ejmech.2011.04.011. Epub 2011 Apr 9.

34.

Small molecule inhibitors of peptidoglycan synthesis targeting the lipid II precursor.

Derouaux A, Turk S, Olrichs NK, Gobec S, Breukink E, Amoroso A, Offant J, Bostock J, Mariner K, Chopra I, Vernet T, Zervosen A, Joris B, Frère JM, Nguyen-Distèche M, Terrak M.

Biochem Pharmacol. 2011 May 1;81(9):1098-105. doi: 10.1016/j.bcp.2011.02.008. Epub 2011 Feb 26.

PMID:
21356201
35.

1,6-AnhMurNAc derivatives for assay development of amidase AmiD.

Mercier F, Zervosen A, Teller N, Frère JM, Herman R, Pennartz A, Joris B, Luxen A.

Bioorg Med Chem. 2010 Nov 1;18(21):7422-31. doi: 10.1016/j.bmc.2010.09.010. Epub 2010 Sep 8.

PMID:
20889346
36.

Dynamics characterization of fully hydrated bacterial cell walls by solid-state NMR: evidence for cooperative binding of metal ions.

Kern T, Giffard M, Hediger S, Amoroso A, Giustini C, Bui NK, Joris B, Bougault C, Vollmer W, Simorre JP.

J Am Chem Soc. 2010 Aug 11;132(31):10911-9. doi: 10.1021/ja104533w.

37.

Antilisterial Activity on Poultry Meat of Amylolysin, a Bacteriocin from Bacillus amyloliquefaciens GA1.

Halimi B, Dortu C, Arguelles-Arias A, Thonart P, Joris B, Fickers P.

Probiotics Antimicrob Proteins. 2010 Jun;2(2):120-5. doi: 10.1007/s12602-010-9040-9.

38.

The surprising diversity of clostridial hydrogenases: a comparative genomic perspective.

Calusinska M, Happe T, Joris B, Wilmotte A.

Microbiology. 2010 Jun;156(Pt 6):1575-88. doi: 10.1099/mic.0.032771-0. Epub 2010 Apr 15. Review.

39.

Standardized evaluation of protein stability.

Thomas A, Joris B, Brasseur R.

Biochim Biophys Acta. 2010 Jun;1804(6):1265-71. doi: 10.1016/j.bbapap.2010.02.008. Epub 2010 Feb 20. Review.

PMID:
20176144
40.

Specific structural features of the N-acetylmuramoyl-L-alanine amidase AmiD from Escherichia coli and mechanistic implications for enzymes of this family.

Kerff F, Petrella S, Mercier F, Sauvage E, Herman R, Pennartz A, Zervosen A, Luxen A, Frère JM, Joris B, Charlier P.

J Mol Biol. 2010 Mar 19;397(1):249-59. doi: 10.1016/j.jmb.2009.12.038. Epub 2009 Dec 28.

PMID:
20036252
41.

Bacillus amyloliquefaciens GA1 as a source of potent antibiotics and other secondary metabolites for biocontrol of plant pathogens.

Arguelles-Arias A, Ongena M, Halimi B, Lara Y, Brans A, Joris B, Fickers P.

Microb Cell Fact. 2009 Nov 26;8:63. doi: 10.1186/1475-2859-8-63.

42.

Structural basis of the inhibition of class A beta-lactamases and penicillin-binding proteins by 6-beta-iodopenicillanate.

Sauvage E, Zervosen A, Dive G, Herman R, Amoroso A, Joris B, Fonzé E, Pratt RF, Luxen A, Charlier P, Kerff F.

J Am Chem Soc. 2009 Oct 28;131(42):15262-9. doi: 10.1021/ja9051526.

43.

Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.

Henry X, Amoroso A, Coyette J, Joris B.

Antimicrob Agents Chemother. 2010 Feb;54(2):953-5. doi: 10.1128/AAC.00983-09. Epub 2009 Nov 16.

44.

Characterisation of an Antilisterial Bacteriocin Produced by Lactobacillus sakei CWBI-B1365 Isolated from Raw Poultry Meat and Determination of Factors Controlling its Production.

Dortu C, Fickers P, Franz CM, Ndagano D, Huch M, Holzapfel WH, Joris B, Thonart P.

Probiotics Antimicrob Proteins. 2009 Jun;1(1):75. doi: 10.1007/s12602-008-9000-9. Epub 2009 Feb 18.

PMID:
26783133
45.

High-level biosynthesis of the anteiso-C(17) isoform of the antibiotic mycosubtilin in Bacillus subtilis and characterization of its candidacidal activity.

Fickers P, Guez JS, Damblon C, Leclère V, Béchet M, Jacques P, Joris B.

Appl Environ Microbiol. 2009 Jul;75(13):4636-40. doi: 10.1128/AEM.00548-09. Epub 2009 May 8.

46.

Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Lemaire S, Glupczynski Y, Duval V, Joris B, Tulkens PM, Van Bambeke F.

Antimicrob Agents Chemother. 2009 Jun;53(6):2289-97. doi: 10.1128/AAC.01135-08. Epub 2009 Mar 16.

47.

Substrate-induced inactivation of the Escherichia coli AmiD N-acetylmuramoyl-L-alanine amidase highlights a new strategy to inhibit this class of enzyme.

Pennartz A, Généreux C, Parquet C, Mengin-Lecreulx D, Joris B.

Antimicrob Agents Chemother. 2009 Jul;53(7):2991-7. doi: 10.1128/AAC.01520-07. Epub 2009 Feb 23.

48.

Crystal structure and activity of Bacillus subtilis YoaJ (EXLX1), a bacterial expansin that promotes root colonization.

Kerff F, Amoroso A, Herman R, Sauvage E, Petrella S, Filée P, Charlier P, Joris B, Tabuchi A, Nikolaidis N, Cosgrove DJ.

Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):16876-81. doi: 10.1073/pnas.0809382105. Epub 2008 Oct 29.

49.

Temperature dependence of mycosubtilin homologue production in Bacillus subtilis ATCC6633.

Fickers P, Leclère V, Guez JS, Béchet M, Coucheney F, Joris B, Jacques P.

Res Microbiol. 2008 Jul-Aug;159(6):449-57. doi: 10.1016/j.resmic.2008.05.004. Epub 2008 Jun 18.

PMID:
18656330
50.

Toward the characterization of peptidoglycan structure and protein-peptidoglycan interactions by solid-state NMR spectroscopy.

Kern T, Hediger S, Müller P, Giustini C, Joris B, Bougault C, Vollmer W, Simorre JP.

J Am Chem Soc. 2008 Apr 30;130(17):5618-9. doi: 10.1021/ja7108135. Epub 2008 Apr 5.

PMID:
18393418

Supplemental Content

Support Center